On June 13, 2019, AIMI Photography successfully signed a contract with Guangzhou Baiyunshan Dubai Bio, a subsidiary of Guangzhou Pharmaceutical Group. In the future, the two sides will launch in-depth cooperation in graphic photography and advertising video production for products in the health care category.

Guangzhou Baiyunshan Baidi Biopharmaceutical Co., Ltd. is a core enterprise of biopharmaceutical R&D and industrialization under Guangzhou Pharmaceutical Group, producing a variety of products such as genetic engineering drugs, human vaccines, medical devices, health care products, food and so on, and the "Therapeutic Dual-Plasmid Anti-Hepatitis B Gene Vaccine" currently under research and development is the first domestic and international gene drug for the treatment of Hepatitis B and the "863" project of the State, a National Class I New Drug, is carrying out special clinical trials. National "863" project, the national first class new drug, is carrying out special clinical trial research.
"Not only photography, but also marketing" Guangzhou AIMI Photography Co., Ltd. with unique marketing perspective, deep technical support to win the recognition of the majority of brand customers, inspired us to provide customers with more valuable services.
Related Articles